Participate in Share Chat. Set up virtual watchlists and portfolios See more trades and share info.
Register for FREE Now
trawl
Posted in: PRTC
Posts: 251
Robert Lyne was ceo of arix when rtw acquired it Nov 2023 hopefully some corporate action will shake things up here
Posted in: PRIM
It looks like Stephen ball picked up another 2 mil shares
There may be circumstances where the lock in is no longer in place
Shareholders with a substantial holding felt strong enough to vote against resolution 7 and 8
Some body bought half a mil shares late today Interesting
It's probably just in case The last ac didn't show a lot of cash Unless there's a sale of something
Posted in: AXL
The interview relates to year end In Feb the balance was up to 22 mil Then in April up to 25 Mill It's probably still increasing
There should be an update soon I wonder has the fmi business been sold its over a year since this was mentioned
Also 1 month after they stated enough cash for 3 years cobenfy was approved they received 29 mil from bms
Considering they did a tender offer at 2.50 It would be nice to get that but this will surely be an opportunitisic bid if it arrives
It's trading at close to cash This would be the perfect time for the co to be buying its own shares
Posted in: JSE
Between the hedge and fixed price for gas The downside should be limited
I think aktara gas is a fixed price of 5.6 dollars per mmbtu which seems good as international price is about 4 dollars
In June 2023 the company said it was required to hedge 50 % of forecast production About 5 mil barrels through till qtr 3 2025 At approx 70.5 dollars a barrel
There was talk of another drill after sk11 And a gas field sitting on top Also possible tax allowance So maybe extending the life has other benefits
The whole biotech sector is similar The rtw biotech opp nav was 1.79 on 14th Mar The share price is 1.23 even though Rob wong has purchased 20 mil shares in the last year
I believe it was 365 mil dollars as they always quote dollars That's about 281 mil gbp
If year end cash was 365 mil dollars that is about 87% of current mkt cap Seems like huge under valuation
In Aug they said they had cash for at least 3 years Since then cobenfy has been approved so there should be no problems with cash
I took the opportunity this morning to reduce my average price If year end cash is 360 mil dlrs That's 1.20 gbp per share
Create a free LSE account to:
Already have an account? Sign In
Don't have an account? Register for FREE